(2001) Asthma,

(1998) Inflammatory cell distribution within and along asthmatic airways,

(1996) Alveolar tissue inflammation in asthma,

(1998) Airway inflammation in mild intermittent and in persistent asthma,

(1989) Association of asthma with serum IgE levels and skin-test reactivity to allergens,

(2000) Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus,

(2002) A new element in the mechanism of asthma,

(2004) National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma, Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health

(1998) Interleukin-13:central mediator of allergic asthma,

(1998) Molecular mechanisms of immunoglobulin E regulation,

(1998) Biochemical events in basophil or mast cell activation and mediator release, Mosby?Year Book

(1997) Complexity and redundancy in the pathogenesis of asthma:reassessing the roles of mast cells and T cells,

(1996) Mast cell effector mechanisms,

(1995) Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep,

(2000) G protein variation in respiratory syncytial virus group A does not correlate with clinical severity,

(1998) Late phase allergic reactions, Mosby?Year Book

(1992) Interleukin-5,eosinophils,and disease,

(1998) Eosinophilia,

(1997) Cellular adhesion and its antagonism,

(1999) Molecular basis for selective eosinophil trafficking in asthma:a multistep paradigm,

(1995) Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation,

(1998) Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells,

(2000) Molecular pathology of allergic disease. I. Lower airway disease.,

(1999) Gene expression of the GATA-3 transcription factor is increased in atopic asthma,

(1992) Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma,

(1994) Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia,

(1984) Decreased suppressor cell activity of alveolar macrophages in bronchial asthma,

(1994) Alveolar macrophage-induced suppression of T-cell hyperresponsiveness in bronchial asthma is reversed by allergen exposure,

(1999) Cytokines in asthma,

(1990) Myofibroblasts and subepithelial fibrosis in bronchial asthma,

(1992) Quantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor,

(1997) Lysophosphatidic acid and EGF stimulate mitogenesis in human airway smooth muscle cells,

(1999) Characterization of the human cysteinyl leukotriene CysLT1 receptor,

(1997) A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis,

(1996) Platelet-activating factor acetylhydrolase deficiency : a missense mutation near the active site of an anti-inflammatory phospholipase,

(1999) Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma,

(1999) IL-9 pathway in asthma new therapeutic targets for allergic inflammatory disorders,

(1998) Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice,

(2000) A role for the C3a anaphylatoxin receptor in the effector phase of asthma,

(2000) Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma,

(1997) Endothelin-1 levels in induced sputum samples from asthmatic and normal subjects,

(1997) Airway endothelin levels in asthma influence of endobronchial allergen challenge and maintenance corticosteroid therapy,

(1997) Immunoreactive endothelin in bronchial biopsy specimens increased expression in asthma and modulation by corticosteroid therapy,

(1991) Endogenous nitric oxide is present in the exhaled air of rabbits,

(1994) Increased nitric oxide in exhaled air of asthmatic patients.Lancet,

(1996) Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects.,

(1998) Correlation between exhaled nitric oxide and methacholine responsiveness in patients with mild asthma,

(1998) Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase effect of inhaled glucocorticoid,

(1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases,

(1998) Activation and localization of transcription factor, nuclear factor-kappaB, in asthma,

(1992) Effect of interleukin-1 receptor antagonist on antigen-induced pulmonary responses in guinea pigs.Eur J Pharmacol,

(1997) Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy,

(1994) Interleukin-10 and its receptor.Ther Immunol,

(1995) Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms,

(1996) Interleukin-10 regulation in normal subjects and patients with asthma.,

(1998) Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha and interferon-gamma release from alveolar macrophages in asthma,

(1994) Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma,

(2000) Innate immunity,

(2004) Understanding asthma pathogenesis:linking innate and adaptive immunity,

(1993) Elevate release of tumor necrosis factor-? and interferon-? by bron-choalveolar leukocytes from patients with bronchial asthma,

(1996) T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma,

(2004) Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma,

(2005) A centennial history of research on asthma pathogenesis,

(2005) A centennial history of research on asthma pathogenesis,